Ulta Beauty, Inc. (ULTA) stock analysis
Close on Nov 12, 2026Market cap $27.83BP/E 23.7Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed11 of 30 checks passed
Ulta Beauty passes 11 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 2/6
- Past performance
- 5/6
- Financial health
- 4/6
- Dividend
- 0/6
What stands out
Return on equity over 15%
Return on equity was 46.1% over the last twelve months and averaged 56.4% over five years.
Return on capital over 10%
Return on invested capital was 45.2%, above the 10% that usually covers the cost of capital.
Low debt
Debt is 12.8% of shareholders' equity, under the 40% we consider low.
Earnings grew over 5 years
Net income grew 45.7% a year on average over the last five fiscal years.
What to watch
Margin of safety under 20%
The price is 36.8% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $659.08 is above our fair value estimate of $481.91.
Revenue growing under 10% a year
Revenue grew 6.7% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 2.2% a year over the last three fiscal years.
Valuation0/6
P/E above its 5-year median
Ulta Beauty's P/E of 24.0 is above its own 5-year median of 19.6.
P/E above the industry
Ulta Beauty's P/E of 24.0 is above the Miscellaneous Retail median of 17.9.
EV/EBITDA above its 5-year median
Ulta Beauty's EV/EBITDA of 14.6 is above its 5-year median of 12.2.
P/B above the industry
Ulta Beauty's price-to-book of 10.66 is above the Miscellaneous Retail median of 2.05.
Trading above fair value
The share price of $659.08 is above our fair value estimate of $481.91.
Margin of safety under 20%
The price is 36.8% above fair value, so there is no margin of safety.
Growth2/6
Revenue growing under 10% a year
Revenue grew 6.7% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew 2.2% a year over the last three fiscal years.
Earnings growth not accelerating
Net income grew 0.7% over the last twelve months, against a 5-year average of 45.7% a year.
Growing faster than the industry
Revenue grew 11.2% over the last twelve months; the Miscellaneous Retail median is 2.6%.
Guidance issued
The latest outlook (Fiscal 2026 Net sales growth, Mar 12, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 39.3% over the last twelve months, against 39.0% a year earlier.
Past performance5/6
Return on equity over 15%
Return on equity was 46.1% over the last twelve months and averaged 56.4% over five years.
Return on capital over 10%
Return on invested capital was 45.2%, above the 10% that usually covers the cost of capital.
Return on equity above the industry
Ulta Beauty's return on equity of 46.1% is above the Miscellaneous Retail median of -3.7%.
Earnings grew over 5 years
Net income grew 45.7% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 9.3% over the last twelve months, against a 5-year average of 11.0%.
Net margin above the industry
Ulta Beauty's net margin of 9.3% is above the Miscellaneous Retail median of -2.5%.
Financial health4/6
Low debt
Debt is 12.8% of shareholders' equity, under the 40% we consider low.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 462% of total debt.
Interest coverage
Interest expense is not reported separately.
Short-term assets cover short-term debts
Current assets are 1.35 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 6.99; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Ulta Beauty has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$481.91
The share price is 37% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 18.8× | 19.6× | 17.9× | $514.92 | 44% |
| EV/EBITDA | 11.5× | 12.2× | 10.8× | $516.33 | 39% |
| Earnings power | 8.7% cost of equity | – | – | $313.56 | 17% |
| Fair value | $481.91 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 19.6
- Miscellaneous Retail median 17.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $278.76M
- Value traded per 1% price move
- $196.35M
Downside
Medium risk
- Typical loss in a bad month
- 24.2%
- Volatility (annualized)
- 36%
- Sharpe ratio, 1 year
- 0.65
- Beta to the S&P 500 (5Y)
- 0.77
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +9.7% | +6.7% | +15.0% | +12.2% | |
| Gross profit | +10.4% | +6.2% | +20.0% | +13.3% | |
| Operating income | -2.0% | -2.2% | +45.3% | +11.7% | |
| Net income | -4.0% | -2.4% | +45.7% | +13.7% | |
| EPS, diluted | +1.2% | +2.2% | +52.5% | +17.8% | |
| Free cash flow | +10.8% | -3.0% | +10.2% | +30.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 27.4% | 9.0% | 43.6% | |
| Return on assets | 17.1% | 3.5% | 17.7% | |
| Current ratio | 2.90 | 1.87 | 1.41 | |
| Capex to revenue | 7.7% | 2.5% | 3.5% | |
| Diluted shares | 63M | 57M | 45M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Ulta Beauty generated $6.86B from operations and spent $7.05B on capital expenditure, dividends and share buybacks. 25% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 9.3% | 1.91× | 2.46× | 43.6% |
| FY2024 | 10.6% | 1.93× | 2.46× | 50.4% |
| FY2023 | 11.5% | 2.02× | 2.61× | 60.9% |
| FY2022 | 12.2% | 2.01× | 2.90× | 71.1% |
| FY2021 | 11.4% | 1.75× | 2.79× | 55.8% |
| FY2020 | 2.9% | 1.24× | 2.55× | 9.0% |
| FY2019 | 9.5% | 1.84× | 2.16× | 37.9% |
| FY2018 | 9.8% | 2.20× | 1.70× | 36.6% |
| FY2017 | 9.4% | 2.16× | 1.64× | 33.4% |
| FY2016 | 8.4% | 2.03× | 1.60× | 27.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.15B
- Cash generatingOperating cash flow above zero$1.50B
- Return on assets improvedROA up on the prior year21.0% → 19.2%
- Earnings backed by cashOperating cash flow above net income$1.50B vs $1.15B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose1.70 → 1.41
- No dilutionShare count did not rise47M → 45M
- Gross margin improvedGross margin up on the prior year38.84% → 39.10%
- More efficientAsset turnover rose1.98 → 2.06
See a number that looks wrong?